MedPath
FDA Approval

Betaine Anhydrous

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 18, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Betaine(1 g in 1 g)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Eton Pharmaceuticals, Inc.

080870465

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Amino GmbH

Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc.

507524424

University of Iowa Pharmaceuticals

Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc.

968854286

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Betaine Anhydrous

Product Details

NDC Product Code
71863-115
Application Number
ANDA210508
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 18, 2023
BetaineActive
Code: 3SCV180C9WClass: ACTIBQuantity: 1 g in 1 g
© Copyright 2025. All Rights Reserved by MedPath